So far, the N-terminal prohormone of the brain natriuretic peptide (NTproBNP) is the only prognostic biomarker included in international pulmonary hypertension (PH) treatment guidelines and risk scores [12,13]. This evidence concerns the gene NPPB and pulmonary arterial hypertension.